Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Allogeneic Stem Cell Transplantation of NiCord, Umbilical Cord Blood-derived Ex Vivo Expanded Stem and Progenitor Cells, in Adolescent and Adult Patients With Hematological Malignancies

Next Previous
X
Search
Trial Profile

Allogeneic Stem Cell Transplantation of NiCord, Umbilical Cord Blood-derived Ex Vivo Expanded Stem and Progenitor Cells, in Adolescent and Adult Patients With Hematological Malignancies

Status: Completed
Phase of Trial: Phase I/II

Latest Information Update: 22 Dec 2021

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Omidubicel (Primary)
  • Indications Acute myeloid leukaemia; Haematological malignancies; Myelodysplastic syndromes; Precursor cell lymphoblastic leukaemia-lymphoma
  • Focus Therapeutic Use
  • Sponsors Gamida-Cell

    • Most Recent Events

    • 26 Jul 2021 Results assessing the recovery of T-, B-, natural killer (NK)-cell, monocyte, and dendritic cell (DC) subsets, published in the Bone Marrow Transplantation.
    • 31 May 2019 According to a Gamida Cell media release, summary of clinical and translational data (two presentations) from this study were presented at the International Society for Cellular and Gene Therapy 2019 Annual Meeting (ISCT 2019).
    • 31 May 2019 Results (summary of clinical and translational data) from this phase 1/2 study in patients with high-risk hematologic malignancies, or blood cancers presented in a Gamida Cell media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top